1. Home
  2. INUV vs CALC Comparison

INUV vs CALC Comparison

Compare INUV & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$0.72

Market Cap

18.0M

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$0.57

Market Cap

19.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INUV
CALC
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.0M
19.1M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
INUV
CALC
Price
$0.72
$0.57
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$11.00
$10.00
AVG Volume (30 Days)
280.0K
294.7K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
N/A
N/A
Revenue
$86,209,305.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.89
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.88
N/A
52 Week Low
$0.71
$0.46
52 Week High
$4.42
$7.20

Technical Indicators

Market Signals
Indicator
INUV
CALC
Relative Strength Index (RSI) 30.92 38.48
Support Level N/A $0.51
Resistance Level $1.16 $0.77
Average True Range (ATR) 0.08 0.05
MACD -0.02 -0.01
Stochastic Oscillator 5.76 4.18

Price Performance

Historical Comparison
INUV
CALC

About INUV Inuvo Inc.

Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

Share on Social Networks: